✦ LIBER ✦

Clinical use of c2 monitoring in long-term liver transplant recipients

✍ Scribed by M Sterneck; K.M Zadeh; R Grotelüschen; D Bröring; X Rogiers; L Fischer

Book ID: 117232758
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 93 KB
Volume: 34
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(02)03567-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

clinical benefit of monitoring cyclospor

clinical benefit of monitoring cyclosporine C2 and C4 in long-term liver transplant recipients

✍ O Barakat; R Peaston; R Rai; D Talbot; D Manas 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Neoral C2 monitoring in pediatric liver

Neoral C2 monitoring in pediatric liver transplant recipients

✍ S. Dunn; K. Falkenstein; G. Cooney 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Comparison of C0 and C2 cyclosporine mon

Comparison of C0 and C2 cyclosporine monitoring in long-term renal transplant recipients

✍ R Marcén; J Pascual; A Tato; J.J Villafruela; J.L Teruel; M.E Rivera; M Tenorio; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Cyclosporine monitoring in stable, long-

Cyclosporine monitoring in stable, long-term, pediatric kidney transplant recipients: the value of C2 determination

✍ M Ferraresso; L Ghio; S Tirelli; P Pedotti; E Taioli; A Edefonti; L Berardinelli 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Steroid withdrawal in long-term liver tr

Steroid withdrawal in long-term liver transplant recipients

✍ M Sterneck; L Fischer; C Weise; D Broering; X Rogiers 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Nicardipine as antihypertensive therapy

Nicardipine as antihypertensive therapy in liver transplant recipients: Results of long-term use

✍ C Duvoux; D Cherqui; V Di Martino; J Métreau; A Salvat; J Lauzet; P Fagniez; D D 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 1 views

antihypertensive therapy. 6 Nicardipine, a 1-4 dihydropyri-Arterial hypertension is frequent in liver transplant dine CCB efficient to control arterial hypertension 7,8 is availrecipients on cyclosporine A (CsA). Nicardipine is a calable in an intravenous form which makes its use very convecium chan